Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression

被引:48
|
作者
Bi, Ye [1 ]
Shirure, Venktesh S. [2 ]
Liu, Ruiyang [3 ,4 ]
Cunningham, Cassandra [1 ]
Ding, Li [3 ,4 ]
Meacham, J. Mark [5 ]
Goedegebuure, S. Peter [1 ,6 ]
George, Steven C. [2 ]
Fields, Ryan C. [1 ,6 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA
[3] Washington Univ, Dept Med, St Louis, MO 63110 USA
[4] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA
[5] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA
[6] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
tumor-on-a-chip; macrophage; angiogenesis; tumor invasion; VON-WILLEBRAND-FACTOR; TISSUE INHIBITOR; CANCER; ANGIOGENESIS; MICROVESSELS; MECHANISMS; EXPRESSION; MODELS;
D O I
10.1093/intbio/zyaa017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor-infiltrating leukocytes, in particular macrophages, play an important role in tumor behavior and clinical outcome. The spectrum of macrophage subtypes ranges from antitumor 'M1'-type to protumor 'M2'-type macrophages. Tumor-associated macrophages (TAMs) typically display phenotypic features of both M1 and M2, and the population distribution is thought to be dynamic and evolves as the tumor progresses. However, our understanding of how TAMs impact the tumor microenvironment remains limited by the lack of appropriate 3D in vitro models that can capture cell-cell dynamics at high spatial and temporal resolution. Using our recently developed microphysiological 'tumor-on-a-chip' (TOC) device, we present here our findings on the impact of defined macrophage subsets on tumor behavior. The TOC device design contains three adjacent and connected chambers in which both the upper and lower chambers are loaded with tumor cells, whereas the central chamber contains a dynamic, perfused, living microvascular network. Introduction of human pancreatic or colorectal cancer cells together with M1-polarized macrophages significantly inhibited tumor growth and tumor-induced angiogenesis. Protein analysis and antibody-based neutralization studies confirmed that these effects were mediated through production of C-X-C motif chemokines (CXCL9), CXCL10 and CXCL11. By contrast, M2-macrophages mediated increased tumor cell migration into the vascularized chamber and did not inhibit tumor growth or angiogenesis. In fact, single-cell RNA sequencing showed that M2 macrophages further segregated endothelial cells into two distinct subsets, corresponding to static cells in vessels versus active cells involved in angiogenesis. The impact of M2 macrophages was mediated mostly by production of matrix metalloproteinase 7 and angiopoietin 2. In summary, our data demonstrate the utility of the TOC device to mechanistically probe biological questions in a 3D in vitro microenvironment.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 50 条
  • [1] The design basis and application in urology of the tumor-on-a-chip platform
    Sheng, Fei
    Jia, Rui-peng
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (07) : 331 - 342
  • [2] A Tumor-on-a-Chip Platform for Screening Precision Driven Medicines
    Forsythe, S.
    Mehta, N.
    Devarasetty, M.
    Mazzochi, A.
    Votanopoulos, K.
    Gmeiner, W.
    Skardal, A.
    TISSUE ENGINEERING PART A, 2017, 23 : S23 - S23
  • [3] Personalized Immunocompetent Tumor-on-a-Chip Platform Produces Tumor-Reactive Cytotoxic Lymphocytes
    Hutchins, D. C.
    Schaaf, C. R.
    Edenhoffer, N.
    Kooshki, M.
    Hall, A. R.
    Miller, L.
    Triozzi, P.
    Soker, S.
    Votanopoulos, K.
    TISSUE ENGINEERING PART A, 2023, 29 (9-10)
  • [4] Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids
    Shirure, Venktesh S.
    Bi, Ye
    Curtis, Matthew B.
    Lezia, Andrew
    Goedegebuure, Madeleine M.
    Goedegebuure, S. Peter
    Aft, Rebecca
    Fields, Ryan C.
    George, Steven C.
    LAB ON A CHIP, 2018, 18 (23) : 3687 - 3702
  • [5] A Tumor-on-a-chip Platform For Screening Precision Medicine-driven Therapies
    Forsythe, S.
    Mehta, N.
    Alistar, A.
    Hall, A.
    Skardal, A.
    TISSUE ENGINEERING PART A, 2016, 22 : S35 - S36
  • [6] Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform
    Aung, Aereas
    Theprungsirikul, Jomkuan
    Lim, Han Liang
    Varghese, Shyni
    LAB ON A CHIP, 2016, 16 (10) : 1886 - 1898
  • [7] Acoustic bubble for spheroid trapping, rotation, and culture: a tumor-on-a-chip platform (ABSTRACT platform)
    Gao, Yuan
    Wu, Mengren
    Luan, Qiyue
    Papautsky, Ian
    Xu, Jie
    LAB ON A CHIP, 2022, 22 (04) : 805 - 813
  • [8] Recent advances in vascularized tumor-on-a-chip
    Huang, Christina Bao Xian
    Tu, Ting-Yuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Development of a Tumor-on-a-Chip for Hypoxia Studies
    Walker, G.
    Beach, S.
    Gamcsik, M.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2017, 53 : S7 - S8
  • [10] High-Throughput Tumor-on-a-Chip Platform to Study Tumor-Stroma Interactions and Drug Pharmacokinetics
    Chi, Chun-Wei
    Lao, Yeh-Hsing
    Ahmed, A. H. Rezwanuddin
    Benoy, Elizabeth C.
    Li, Chenghai
    Dereli-Korkut, Zeynep
    Fu, Bingmei M.
    Leong, Kam W.
    Wang, Sihong
    ADVANCED HEALTHCARE MATERIALS, 2020, 9 (21)